Migraine

Results of post hoc analyses highlight erenumab's efficacy in reducing headache medication use among migraineurs.

Results of a UK Biobank study outline the association between migraine and several gastrointestinal disorders.

Results of a survey study underscore the variables considered most and least important to patients and general practitioners when it comes to migraine treatments.

New research underscores the strong association seen between migraine, hearing loss, and tinnitus among US adults.

Early assessment of risks for other disorders may significantly improve long-term outcomes.

Highlighting the latest migraine-related news reported across MJH Life Sciences™.

Introducing more n-3 acids into one’s diet can mitigate headache pain for migraineurs.

Results of an online survey indicated that remote electrical neuromodulation (REN) may serve as a nonpharmocological treatment option for patients with menstrual migraine.

New research illustrates the potential benefits of erenumab among migraineurs in the United States.

Research presented at the American Headache Society's 63rd Annual Scientific Meeting outlines the association between migraine and history of mild traumatic brain injury.

Women who endure migraine are more susceptible to the development of obstetric and postpartum complications when pregnant, according to study results.

Some demographic groups face more limitations than others when seeking and receiving appropriate care for their headache disorders due to treatment disparities.

Study results show that those with migraine are more likely to develop rheumatoid arthritis (RA) and those with RA are also more likely to have migraine.

Survey results illustrate the detrimental effects of migraine on daily life.

Almost half of US migraineurs hesitate to seek out care for their condition, according to research presented at the American Headache Society's 63rd Annual Scientific Meeting.

Results of an observational study indicate low estradiol levels could worsen vestibular migraine in postmenopausal women.

Findings from an observational study indicate that chronic migraineurs with medication overuse headache may be deficient in vitamin D.

Analyses showed differential brain activity among migraineurs with anxiety compared with those without anxiety and healthy controls.

Results from a genome-wide association study indicate blood clot factors may contribute to the cause of migraine with aura.

Results of a US claims database show erenumab is associated with reduced acute medication use and health care resource utilization.

Real-world data collected from 5 US health centers highlight erenumab's efficacy in chronic migraineurs.

Data show male migraineurs are nearly 6 times as likely to develop abdominal aortic aneurysms compared with healthy females.

An observational study reveals COVID-19 social distancing measures affected migraineurs' sleep, physical activity.

Using transcranial sonography, researchers uncovered a potential imaging biomarker for depression among migraineurs.

In a review, researchers examined potential mechanisms contributing to the hereditary nature of migraine.

Results of a longitudinal cohort study conducted in France suggest post-menopausal women who have a history of migraine may be at an increased risk of developing hypertension.

Study results highlight the economic toll of migraine on employers in Japan.

Research presented at the American Academy of Neurology's annual meeting indicates some air pollutants may be associated with increased rates of migraine prevalence and severity.

Data from a single health system show women who present to the emergency department for headache tend to do so during the preovulatory interval of their menstrual cycle.

Results of a questionnaire-based study show higher body mass index (BMI) is associated with worse migraine symptoms and comorbidities.